Tinidazole prophylaxis in elective abdominal hysterectomy

Int J Gynaecol Obstet. 1993 Aug;42(2):121-5. doi: 10.1016/0020-7292(93)90624-6.

Abstract

Objective: To determine whether a single dose (2 g) of tinidazole before abdominal hysterectomy could reduce the incidence of postoperative infection.

Method: A randomized double-blind placebo-controlled study was undertaken with a single oral dose (2 g) of tinidazole, 12 h before surgery, in 100 patients undergoing abdominal hysterectomy for various benign diseases. Other antibiotic use was withheld until there was no postoperative infection.

Result: A significant reduction (P < 0.05) of infectious morbidity (28% vs. 8%) as well as a decrease in additional antibiotic use (P < 0.01) and duration of hospital stay (P < 0.001) was observed. Febrile morbidity was also reduced from 36% to 14% (P < 0.05). Tinidazole was tolerated well by all the patients.

Conclusion: Tinidazole prophylaxis (2 g oral dose) is considered to be a simple, safe and effective way to reduce postoperative infection in abdominal hysterectomy.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Double-Blind Method
  • Female
  • Humans
  • Hysterectomy*
  • Incidence
  • Middle Aged
  • Morbidity
  • Premedication*
  • Prospective Studies
  • Surgical Wound Infection / epidemiology
  • Surgical Wound Infection / microbiology
  • Surgical Wound Infection / prevention & control*
  • Tinidazole / administration & dosage*
  • Tinidazole / therapeutic use

Substances

  • Tinidazole